TAG:
lab test
Payer Consolidation: United Buys Pacificare
By Robert Michel | From the Volume XII No. 10 – July 11, 2005 Issue
CEO SUMMARY: For the second time in nine months, a health insurer company has spent around $9 billion to grow by acquisition. This time, it is UnitedHealth Group purchasing PacifiCare Health Systems. These types of deals impact local labs and pathology groups as existing contracts expire….
DOJ Sends Subpoenas To Quest & LabCorp
By Robert Michel | From the Volume XII No. 9 – June 20, 2005 Issue
CEO SUMMARY: In Newark, New Jersey, the Office of the U.S. Attorney served subpoenas to each of the two blood brothers, seeking information on “capitation and risk-sharing arrangements with government and private payers for the years 1993 through 1999.” At this point, little is known …
Patient ABNs Can Save On Expensive Send-outs
By Robert Michel | From the Volume XII No. 9 – June 20, 2005 Issue
CEO SUMMARY: Throughout the United States, the growing number of high-priced, patent-protected specialty tests is eating into the laboratory budgets of many hospitals. At Hospital Consolidated Laboratories in Southfield, Michigan, this budget-busting threat triggered an innovative respons…
LIS Market Evolving To Serve New Needs
By Robert Michel | From the Volume XII No. 8 – May 30, 2005 Issue
CEO SUMMARY: Ongoing reimbursement declines, coupled with other key factors, are pushing labs to seek new capabilities for their laboratory information systems (LIS). Another influence is the growth of molecular diagnostic programs in hospital labs. Molecular testing places unique demands…
“Coming Out” Party In Atlanta for IQLM
By Robert Michel | From the Volume XII No. 7 – May 9, 2005 Issue
CEO SUMMARY: It was like a debutante ball for the fledgling Institute for Quality in Laboratory Medicine (IQLM). Over three days, thought leaders in healthcare and laboratory testing tackled the issue of how laboratory medicine can improve patient safety and contribute to higher-quality h…
JCAHO, NQF CEOs Speak to Lab’s Future Role
By Robert Michel | From the Volume XII No. 7 – May 9, 2005 Issue
CEO SUMMARY: What an opportunity! On the same podium were the presidents of both the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and the National Quality Forum (NQF), specifically to speak about laboratory medicine’s role in the evolution of the nation’s heal…
Ramifications From The “H2N2 Virus Affair”
By Robert Michel | From the Volume XII No. 7 – May 9, 2005 Issue
CEO SUMMARY: Here’s the story, with new details, about how a patient sample, cross-contaminated with a “deadly” strain of influenza virus from a proficiency test kit, triggered alarm bells at the highest levels of public health in Canada, the United States, and the World Health Orga…
Why Is There Crime In the Lab Industry?
By Robert Michel | From the Volume XII No. 7 – May 9, 2005 Issue
CEO SUMMARY: Since 1991, there have been criminal indictments or criminal convictions of four former CEOs of public lab companies. Given the limited number of public lab companies active in the market at any moment in time, this is a remarkably high rate of criminal behavior. Moreover, th…
Ex-IMPATH Executives Face Criminal Charges
By Robert Michel | From the Volume XII No. 6 – April 18, 2005 Issue
CEO SUMMARY: With the announcement by Federal prosecutors of criminal and civil actions against a total of seven ex-IMPATH executives, IMPATH becomes the laboratory industry’s worst criminal scandal. Federal prosecutors contend these executives, during their employment at IMPATH, engine…
Medicare Managed Care Is Poised to Double in Size
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
MEDICARE MANAGED CARE PLANS are poised to double in size. This can be both a threat and an opportunity for regional laboratories. The Center for Medicare and Medicaid Services (CMS) recently reported that it had received 141 applications for new local Medicare Advantage plans for 20…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized